title: Concerns over your recent paper on risperidone long-acting injectable for treatment-resistant schizophrenia.
authors.affiliation: University of Melbourne, Department of Psychiatry, Austin Health, Heidelberg, VIC 3064, Australia. Electronic address: richard.kanaan@unimelb.edu.au.
authors.forename: Richard A
authors.initials: RA
authors.lastname: Kanaan
mesh_terms: D014150:Antipsychotic Agents / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D011618:Psychotic Disorders / Q000150:complications*; D018967:Risperidone / Q000008:administration & dosage*; D012559:Schizophrenia / Q000150:complications* / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents; D018967:Risperidone